Sitidime
Brand Name: Sitidime
Generic Name: Ceftazidime (as pentahydrate)
Active
Registration Number
DR-XY47861
Dosage Form
Powder for Injection (IM/IV)
Issuance Date
March 31, 2022
Expiry Date
March 31, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength1g
Packaging10 mL USP Type I glass vial (Box of l's)
Classification
C
Classification
Prescription Drug (RX)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Ceftazidime (as pentahydrate)Active
Monograph: ceftazidime (as pentahydrate)